[1] Chaitanya V, Lakshmi BS, Kumar AC, et al. Disseminated Trichosporon infection in a renal transplant recipient[J]. Transpl Infect Dis,2015,17(4):605-609.
[2] 丛林, 李海涛, 王文岭, 等. 侵袭性毛孢子菌感染的诊断和治疗[J]. 中国真菌学杂志,2010, 5(3):184-187.
[3] Kudo K, Terui K, Sasaki S, et al. Voriconazole for both successful treatment of disseminated Trichosporon asahii infection and subsequent cord blood transplantation in an infant with acute myelogenous leukemia[J]. Bone Marrow Transplant,2011, 46(2):310-311.
[4] Colombo AL, Padovan AC, Chaves GM. Current knowledge of Trichosporon spp. and trichosporonosis[J]. Clin Microbiol Rev,2011, 24(4):682-700.
[5] Zhang L H, Tai Y, Tong H, et al. Hepatobiliary and pancreatic:rare cause of obstructive jaundice by Trichosporon asahii[J]. J Gastroenterol Hepatol,2018, 33(2):338.
[6] Basiri K, Meidani M, Rezaie F, et al. A rare case of Trichosporon brain abscess, successfully treated with surgical excision and antifungal agents[J]. Neurol Neurochir,2012, 46(1):92-95.
[7] Ruan SY, Chien JY, Hsueh PR. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan[J]. Clin Infect Dis,2009, 49(1):e11-7.
[8] Lee EY, Lian WQD, Iyer P, et al. An unusual cause of fever and rash in a child with severe aplastic anemia[J]. J Pediatr Hematol Oncol,2018, 40(2):156-158.
[9] 郑岳臣, 陶娟, 冯爱平,等. 播散性阿萨希毛孢子菌病一例[J]. 中华皮肤科杂志,2008, 41(1):36-39.
[10] Chen J, Chen F, Wang Y, et al. Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazole[J]. Med Mycol Case Rep,2014,6:55-57.
[11] Pappas PG, Kauffman CA, Andes DR, et al. Executive summary:clinical practice guideline for the management of candidiasis:2016 update by the Infectious Diseases Society of America[J]. Clin Infect Dis,2016, 62(4):409-417.
[12] de Almeida Júnior JN, Hennequin C. Invasive Trichosporon infection:a systematic review on a re-emerging fungal pathogen[J]. Front Microbiol,2016, 7:1629.
[13] Hazirolan G, Canton E, Sahin S, et al. Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii[J]. Antimicrob Agents Chemother,2013, 57(10):4841-4847.
[14] Arendrup MC, Boekhout T, Akova M, et al. European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections[J]. Clin Microbiol Infect,2014, 20(Suppl 3):76-98.